Blackrock Health Sciences Term Trust DEF 14A proxy statements

BlackRock accuses Saba Capital of prioritizing its own profits over the interests of long-term shareholders in closed-end funds.

BlackRock Health Sciences Term Trust (BMEZ) urges shareholders to vote against Saba Capital's proposal to replace the investment advisor and board members at the upcoming annual meeting.

BlackRock Health Sciences Term Trust is urging shareholders to vote against Saba Capital's nominees and proposal to terminate the investment management agreement with BlackRock Advisors, LLC at the upcoming annual meeting.

Saba Capital is soliciting proxies to elect its nominees to the BlackRock Health Sciences Term Trust board and to terminate the current investment management agreement, aiming to address the fund's trading discount and governance issues.

BlackRock Health Sciences Term Trust urges shareholders to vote using the WHITE proxy card to protect their investment against actions proposed by Saba Capital Management.